05Jun
FDA Introduces New Platform Technology Designation Guidance
FDA has taken a landmark step to streamline the drug application process for biotechnology companies by issuing new guidance on platform technology designation. This initiative…
Our blog
Category: Industry News
24May
Parallel Bio Brings Revolutionary “Clinical Trial in a Dish” to Accelerate Drug Discovery
Drug discovery and development is a very strenuous process that takes a lot of time and financial efforts. A drug takes over 10 years and…
30Apr
Moderna Harnessing the Power of AI for Drug Development
In what can be termed as a step towards innovation, pharmaceutical giant Moderna and OpenAI are joining hands to enhance the former’s workforce productivity by…
29Apr
Innovating Healthcare: New FDA Approvals in 2024
In the clinical research industry, every year brings forth remarkable advancements and breakthroughs. FDA plays a pivotal role in approving innovative treatments that offer hope…
03Apr
Crucial FDA Decisions for the Second Quarter of 2024
The life sciences industry has embarked on a promising journey in the early months of 2024, with steady dealmaking and a resurgence in investor confidence.…
23Jan
5 Crucial FDA Decisions to Look Out for in 2024’s Quarter 1
FDA is anticipated to make some key decisions in the first quarter of 2024 with regards to drug approvals. Read about the 5 crucial decisions…
17Oct
Crucial FDA Decisions to Look Out For in Late 2023
FDA is going to make some significant decisions with respect to approval of a few life-changing medical interventions from Pfizer, Bristol Myers Squibb, CRISPR, etc.
